Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Talking Healthtech

The NHS and ABPI at 70: inching closer to the triple win

The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...

- PMLiVE

Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval

A rapid round up of news from pharma, biotech and healthcare

- PMLiVE

KYNE bolsters digital offering

Medit will take the helm of KYNE’s digital strategy

How integrated insights supported a biologic launch strategy across multiple indications

Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their...

Research Partnership

- PMLiVE

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

A rapid round up of pharma, biotech and healthcare news

Sanofi reception

Sanofi’s latecomer PD-1 gets date for FDA verdict

While Keytruda extends its lead, Sanofi makes a late bid to enter PD-1 space

- PMLiVE

Disruptive technologies set to stabilise soaring drug prices

AI and blockchain could accelerate the drug development process, says report

- PMLiVE

BenevolentAI raises $115m to fund drug development

Its technology could cut the early stage drug discovery process by four years, says the company

- PMLiVE

Artificial intelligence in healthcare ‘set for 40% growth to 2024’

And the US, the UK and China are all expected to be front-runners

Sanofi reception

Sanofi’s PD-1 inhibitor starts EU review for skin cancer

Cemiplimab could be the first PD-1-targeting drug approved for CSCC

Bayer looks to leverage AI across the pharma value chain

Dieter Weinand outlines his hopes for applying artificial intelligence

BenevolentAI claims AI first with new Cambridge facility

Says its new drug discovery and development base will cover the entire research process

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links